Image

MediValve has obtained 510(k) pre-marketing clearance from the US Food and Drug Administration for its acWire guidewire, intended for use in peripheral vascular and heart catheterisation procedures, to introduce and assist in positioning diagnostic and interventional devices.

MediValve’s acWire may also function as an alignment tool by providing a reference plane of anatomical structure of interest.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

The acWire guidewire is a single-use, fully disposable medical device utilising shape-memory alloy technology intended to enable identification of cardiovascular structures using existing imaging methods.

It is specifically intended for implantation plane acquisition, during trans-catheter aortic-valve implantation (TAVI) procedures, using fluoroscopic imaging.

acWire identifies exact locations within the cardiovascular system during interventional procures, making it a promising choice for the TAVI interventional procedure.

Once directed to a selected cardiovascular location, acWire is deformable under fluoroscopy to identify a desired specific anatomical landmark for subsequent therapeutic treatment by the clinician.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData
"This is the second in a series of regulatory applications as we continue our development of several additional acWire products."

The company’s acWire promises shorter procedure times, reduced usage of radiation and contrast media, and improved clinical outcomes.

The device relies on latest standard methods and techniques that are used by interventional cardiologists to access the cardiovascular system.

MediValve CEO Assaf Klein said: "In today’s challenging regulatory environment, it is extremely exciting for a young company to achieve both CE and FDA pre-market clearances in the same month. We anticipate significant clinical interest for this innovative technology.

"This is the second in a series of regulatory applications as we continue our development of several additional acWire products."

Recently, the company also obtained CE Mark approval for the acWire guidewire.


Image: MediValve receives FDA 510(k) approval for acWire guidewire. Photo: courtesy of MediValve, Ltd.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
SC MEDICA’s minimally invasive, radiation free spinal facet fixation system, FFX® is transforming spinal pain management and improving outcomes for surgeons and patients alike. Learn how SC MEDICA’s award-winning technology is redefining standards in facet joint pain treatment.

Discover the Impact